Cargando…
The burden of critical limb ischemia: a review of recent literature
Peripheral arterial disease is a chronic vascular disease characterized by impaired circulation to the lower extremities. Its most severe stage, known as critical limb ischemia (CLI), puts patients at an increased risk of cardiovascular events, amputation, and death. The objective of this literature...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617560/ https://www.ncbi.nlm.nih.gov/pubmed/31308682 http://dx.doi.org/10.2147/VHRM.S209241 |
_version_ | 1783433718036168704 |
---|---|
author | Duff, Steve Mafilios, Michael S Bhounsule, Prajakta Hasegawa, James T |
author_facet | Duff, Steve Mafilios, Michael S Bhounsule, Prajakta Hasegawa, James T |
author_sort | Duff, Steve |
collection | PubMed |
description | Peripheral arterial disease is a chronic vascular disease characterized by impaired circulation to the lower extremities. Its most severe stage, known as critical limb ischemia (CLI), puts patients at an increased risk of cardiovascular events, amputation, and death. The objective of this literature review is to describe the burden of disease across a comprehensive set of domains—epidemiologic, clinical, humanistic, and economic—focusing on key studies published in the last decade. CLI prevalence in the United States is estimated to be approximately 2 million and is likely to rise in the coming years given trends in important risk factors such as age, diabetes, and smoking. Hospitalization for CLI patients is common and up to 60% are readmitted within 6 months. Amputation rates are unacceptably high with a disproportionate risk for certain demographic and socioeconomic groups. In addition to limb loss, CLI patients also have reduced life expectancy with mortality typically exceeding 50% by 5 years. Given the poor clinical prognosis, it is unsurprising that the quality of life burden associated with CLI is significant. Studies assessing quality of life in CLI patients have used a variety of generic and disease-specific measures and all document a substantial impact of the disease on the patient’s physical, social, and emotional health status compared to population norms. Finally, the poor clinical outcomes and increased medical resource use lead to a considerable economic burden for national health care systems. However, published cost studies are not comprehensive and, therefore, likely underestimate the true economic impact of CLI. Our summary documents a sobering assessment of CLI burden—a poor clinical prognosis translating into diminished quality of life and high costs for millions of patients. Continued prevention efforts and improved treatment strategies are the key to ameliorating the substantial morbidity and mortality associated with this disease. |
format | Online Article Text |
id | pubmed-6617560 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-66175602019-07-15 The burden of critical limb ischemia: a review of recent literature Duff, Steve Mafilios, Michael S Bhounsule, Prajakta Hasegawa, James T Vasc Health Risk Manag Review Peripheral arterial disease is a chronic vascular disease characterized by impaired circulation to the lower extremities. Its most severe stage, known as critical limb ischemia (CLI), puts patients at an increased risk of cardiovascular events, amputation, and death. The objective of this literature review is to describe the burden of disease across a comprehensive set of domains—epidemiologic, clinical, humanistic, and economic—focusing on key studies published in the last decade. CLI prevalence in the United States is estimated to be approximately 2 million and is likely to rise in the coming years given trends in important risk factors such as age, diabetes, and smoking. Hospitalization for CLI patients is common and up to 60% are readmitted within 6 months. Amputation rates are unacceptably high with a disproportionate risk for certain demographic and socioeconomic groups. In addition to limb loss, CLI patients also have reduced life expectancy with mortality typically exceeding 50% by 5 years. Given the poor clinical prognosis, it is unsurprising that the quality of life burden associated with CLI is significant. Studies assessing quality of life in CLI patients have used a variety of generic and disease-specific measures and all document a substantial impact of the disease on the patient’s physical, social, and emotional health status compared to population norms. Finally, the poor clinical outcomes and increased medical resource use lead to a considerable economic burden for national health care systems. However, published cost studies are not comprehensive and, therefore, likely underestimate the true economic impact of CLI. Our summary documents a sobering assessment of CLI burden—a poor clinical prognosis translating into diminished quality of life and high costs for millions of patients. Continued prevention efforts and improved treatment strategies are the key to ameliorating the substantial morbidity and mortality associated with this disease. Dove 2019-07-01 /pmc/articles/PMC6617560/ /pubmed/31308682 http://dx.doi.org/10.2147/VHRM.S209241 Text en © 2019 Duff et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Duff, Steve Mafilios, Michael S Bhounsule, Prajakta Hasegawa, James T The burden of critical limb ischemia: a review of recent literature |
title | The burden of critical limb ischemia: a review of recent literature |
title_full | The burden of critical limb ischemia: a review of recent literature |
title_fullStr | The burden of critical limb ischemia: a review of recent literature |
title_full_unstemmed | The burden of critical limb ischemia: a review of recent literature |
title_short | The burden of critical limb ischemia: a review of recent literature |
title_sort | burden of critical limb ischemia: a review of recent literature |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617560/ https://www.ncbi.nlm.nih.gov/pubmed/31308682 http://dx.doi.org/10.2147/VHRM.S209241 |
work_keys_str_mv | AT duffsteve theburdenofcriticallimbischemiaareviewofrecentliterature AT mafiliosmichaels theburdenofcriticallimbischemiaareviewofrecentliterature AT bhounsuleprajakta theburdenofcriticallimbischemiaareviewofrecentliterature AT hasegawajamest theburdenofcriticallimbischemiaareviewofrecentliterature AT duffsteve burdenofcriticallimbischemiaareviewofrecentliterature AT mafiliosmichaels burdenofcriticallimbischemiaareviewofrecentliterature AT bhounsuleprajakta burdenofcriticallimbischemiaareviewofrecentliterature AT hasegawajamest burdenofcriticallimbischemiaareviewofrecentliterature |